OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response
Patrick Reimann, Hanno Ulmer, Beatrix Mutschlechner, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 3, pp. 577-584
Open Access | Times Cited: 39
Patrick Reimann, Hanno Ulmer, Beatrix Mutschlechner, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 3, pp. 577-584
Open Access | Times Cited: 39
Showing 26-50 of 39 citing articles:
COVID-19 and Cancer: Special Considerations for Patients Receiving Immunotherapy and Immunosuppressive Cancer Therapies
Jason D. Goldman, Michael A. Gonzalez, Maria Madeleine Rüthrich, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 176-188
Open Access | Times Cited: 10
Jason D. Goldman, Michael A. Gonzalez, Maria Madeleine Rüthrich, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 176-188
Open Access | Times Cited: 10
Predictors of poor serologic response to COVID-19 vaccine in patients with cancer: a systematic review and meta-analysis
Wenxing Yang, Dongxue Zhang, Zhuo Li, et al.
European Journal of Cancer (2022) Vol. 172, pp. 41-50
Open Access | Times Cited: 7
Wenxing Yang, Dongxue Zhang, Zhuo Li, et al.
European Journal of Cancer (2022) Vol. 172, pp. 41-50
Open Access | Times Cited: 7
Cost-Effectiveness of COVID-19 Sequential Vaccination Strategies in Inactivated Vaccinated Individuals in China
Yaqun Fu, Jingyu Zhao, Wei Xia, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1712-1712
Open Access | Times Cited: 7
Yaqun Fu, Jingyu Zhao, Wei Xia, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1712-1712
Open Access | Times Cited: 7
SARS-CoV-2 Immunity in Hematopoietic Stem Cell Transplant and Cell Therapy Recipients: What Do We Know, and What Remains to Be Determined?
José Luís Piñana, Manuel Guerreiro, Carlos Solano
Hemato (2023) Vol. 4, Iss. 2, pp. 170-183
Open Access | Times Cited: 3
José Luís Piñana, Manuel Guerreiro, Carlos Solano
Hemato (2023) Vol. 4, Iss. 2, pp. 170-183
Open Access | Times Cited: 3
Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
Aiquan Chang, Jingyou Yu
Viruses (2022) Vol. 14, Iss. 2, pp. 380-380
Open Access | Times Cited: 5
Aiquan Chang, Jingyou Yu
Viruses (2022) Vol. 14, Iss. 2, pp. 380-380
Open Access | Times Cited: 5
Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art
Nedelcho Ivanov, Boris Krastev, Dimitrina Miteva, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 9, pp. 343-356
Open Access | Times Cited: 2
Nedelcho Ivanov, Boris Krastev, Dimitrina Miteva, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 9, pp. 343-356
Open Access | Times Cited: 2
Acute Hepatitis of Unknown Origin (AHUO)—The Puzzle Ahead
Consolato Sergi
Diagnostics (2022) Vol. 12, Iss. 5, pp. 1215-1215
Open Access | Times Cited: 3
Consolato Sergi
Diagnostics (2022) Vol. 12, Iss. 5, pp. 1215-1215
Open Access | Times Cited: 3
Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia
Alexey A. Komissarov, Maria Kislova, Ivan Molodtsov, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 416-416
Open Access | Times Cited: 3
Alexey A. Komissarov, Maria Kislova, Ivan Molodtsov, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 416-416
Open Access | Times Cited: 3
Effectiveness and Safety of COVID-19 Vaccination in Patients with Malignant Disease
Li Zhao, Lin Fu, Yuqin He, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 486-486
Open Access | Times Cited: 1
Li Zhao, Lin Fu, Yuqin He, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 486-486
Open Access | Times Cited: 1
Adjuvant activities of immunostimulating natural products: Astragalus membranaceus (Fisch.) Bge. and Coriolus versicolor in BNT162b2 vaccination against COVID-19 infection
Ben Chung-Lap Chan, Peiting Li, Miranda Sin‐Man Tsang, et al.
Journal of Leukocyte Biology (2023) Vol. 115, Iss. 1, pp. 177-189
Closed Access | Times Cited: 1
Ben Chung-Lap Chan, Peiting Li, Miranda Sin‐Man Tsang, et al.
Journal of Leukocyte Biology (2023) Vol. 115, Iss. 1, pp. 177-189
Closed Access | Times Cited: 1
Heterologous COVID-19 Booster Vaccination in the Chronic Disorder of Consciousness: A Pilot Study
Maria Elena Pugliese, Riccardo Battaglia, Maria Girolama Raso, et al.
Clinics and Practice (2022) Vol. 12, Iss. 3, pp. 318-325
Open Access | Times Cited: 1
Maria Elena Pugliese, Riccardo Battaglia, Maria Girolama Raso, et al.
Clinics and Practice (2022) Vol. 12, Iss. 3, pp. 318-325
Open Access | Times Cited: 1
COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?
Reut Harel, Gilad Itchaki
Acta Haematologica (2023) Vol. 147, Iss. 1, pp. 60-72
Open Access
Reut Harel, Gilad Itchaki
Acta Haematologica (2023) Vol. 147, Iss. 1, pp. 60-72
Open Access
Literature analysis of the efficacy of COVID-19 vaccinations
Tim Hulsen
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Tim Hulsen
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
